spacer
spacer

PDBsum entry 4xjs

Go to PDB code: 
protein ligands links
Hydrolase, transferase PDB id
4xjs

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
239 a.a.
Ligands
733
HSX
Waters ×23
PDB id:
4xjs
Name: Hydrolase, transferase
Title: Human cd38 complexed with inhibitor 1 [6-fluoro-2-methyl-4-[(2,3,6- trichlorobenzyl)amino]quinoline-8-carboxamide]
Structure: Adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1. Chain: a. Synonym: 2'-phospho-adp-ribosyl cyclase,2'-phospho-adp-ribosyl cyclase/2'-phospho-cyclic-adp-ribose transferase,2'-phospho-cyclic- adp-ribose transferase,adp-ribosyl cyclase 1,adprc 1,cyclic adp- ribose hydrolase 1,cadpr hydrolase 1,t10. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: cd38. Expressed in: pichia. Expression_system_taxid: 4919
Resolution:
2.80Å     R-factor:   0.190     R-free:   0.263
Authors: L.M.Shewchuk,D.Deaton,E.Stewart
Key ref: J.D.Becherer et al. (2015). Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38. J Med Chem, 58, 7021-7056. PubMed id: 26267483 DOI: 10.1021/acs.jmedchem.5b00992
Date:
09-Jan-15     Release date:   26-Aug-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P28907  (CD38_HUMAN) -  ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 from Homo sapiens
Seq:
Struc:
300 a.a.
239 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 4 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: E.C.2.4.99.20  - 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: nicotinate + NADP+ = nicotinate-adenine dinucleotide phosphate + nicotinamide
nicotinate
+ NADP(+)
= nicotinate-adenine dinucleotide phosphate
+ nicotinamide
   Enzyme class 2: E.C.3.2.2.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 3: E.C.3.2.2.6  - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: NAD+ + H2O = ADP-D-ribose + nicotinamide + H+
NAD(+)
+ H2O
= ADP-D-ribose
+ nicotinamide
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/acs.jmedchem.5b00992 J Med Chem 58:7021-7056 (2015)
PubMed id: 26267483  
 
 
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38.
J.D.Becherer, E.E.Boros, T.Y.Carpenter, D.J.Cowan, D.N.Deaton, C.D.Haffner, M.R.Jeune, I.W.Kaldor, J.C.Poole, F.Preugschat, T.R.Rheault, C.A.Schulte, B.G.Shearer, T.W.Shearer, L.M.Shewchuk, T.L.Smalley, E.L.Stewart, J.D.Stuart, J.C.Ulrich.
 
  ABSTRACT  
 
Starting from the micromolar 8-quinoline carboxamide high-throughput screening hit 1a, a systematic exploration of the structure-activity relationships (SAR) of the 4-, 6-, and 8-substituents of the quinoline ring resulted in the identification of approximately 10-100-fold more potent human CD38 inhibitors. Several of these molecules also exhibited pharmacokinetic parameters suitable for in vivo animal studies, including low clearances and decent oral bioavailability. Two of these CD38 inhibitors, 1ah and 1ai, were shown to elevate NAD tissue levels in liver and muscle in a diet-induced obese (DIO) C57BL/6 mouse model. These inhibitor tool compounds will enable further biological studies of the CD38 enzyme as well as the investigation of the therapeutic implications of NAD enhancement in disease models of abnormally low NAD.
 

 

spacer

spacer